ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,371Medicare Part D Prescriptions Filled, Including Refills

Rank: 342 out of 2588

$585K Total Retail Price of All Prescriptions

Rank: 347 out of 2588

535 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

20% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,361 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 439 343 1 1
LISINOPRIL 303 204 2 3
FUROSEMIDE 287 243 3 5
METFORMIN HCL 278 188 4 8
WARFARIN SODIUM 264 184 5 10
AMLODIPINE BESYLATE 244 165 6 4
HYDROCODONE-ACETAMINOPHEN 233 136 S3 7 7
GABAPENTIN 211 143 8 18
METOPROLOL TARTRATE 209 147 9 9
HYDROCHLOROTHIAZIDE 197 140 10 13
OMEPRAZOLE 185 134 11 6
HEPARIN SODIUM 158 99 12 79
FAMOTIDINE 148 102 13 36
TRAMADOL HCL 147 120 14 19
LEVOTHYROXINE SODIUM 145 131 15 2
GLIPIZIDE 144 94 16 44
ENALAPRIL MALEATE 129 113 17 31
DONEPEZIL HCL 126 112 18 22
PROAIR HFA 120 78 19 50
IBUPROFEN 119 71 20 62
LANTUS 115 76 21 47
METOPROLOL SUCCINATE 113 85 22 12
NAMENDA 108 96 23 32
NIFEDIPINE ER 107 91 24 59
TAMSULOSIN HCL 94 76 25 23
ZOLPIDEM TARTRATE 87 63 26 24
DIOVAN 86 62 27 29
ADVAIR DISKUS 85 65 28 48
ALENDRONATE SODIUM 83 68 29 21
POTASSIUM CHLORIDE 78 46 30 15
CARVEDILOL 75 49 31 20
FLUTICASONE PROPIONATE 75 52 31 40
LYRICA 73 62 33 100
ACETAMINOPHEN-CODEINE 72 40 S3 34 80
EXELON 72 64 34 118
PLAVIX 72 42 34 43
SURE COMFORT 71 40 37 227
HUMALOG 70 40 38 141
SPIRONOLACTONE 68 31 39 58
PANTOPRAZOLE SODIUM 68 57 39 28
NIASPAN 67 36 41 115
ATENOLOL 66 43 42 14
HYDRALAZINE HCL 65 43 43 53
RANITIDINE HCL 64 52 44 37
NEXIUM 63 51 45 41
CITALOPRAM HBR 63 45 45 27
COMBIVENT 61 43 47 145
TRAZODONE HCL 61 47 47 61
DIGOXIN 60 46 49 38
ATORVASTATIN CALCIUM 57 41 50 11
NAPROXEN 57 50 50 95
ACTOS 57 49 50 105
POLYETHYLENE GLYCOL 3350 56 42 53 55
GEMFIBROZIL 56 30 53 123
LEVOFLOXACIN 53 40 55 77
SANTYL 50 39 56 160
VENTOLIN HFA 50 23 56 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.